
New York Hospitals Studying Heartburn Drug With Hydroxychloroquine Against COVID-19
Some hospitals in New York are conducting a clinical trial testing the efficacy of famotidine, a common heartburn drug, along with the anti-malarial drug hydroxychloroquine against COVID-19. The randomized, controlled, and double-blind trial is looking at the safety and effectiveness of hydroxychloroquine alone and in combination with famotidine for treating COVID-19 in hospitalized patients. While hydroxychloroquine is being studied in multiple trials